The POU domain of SCIP/Tst-1/Oct-6 is sufficient for activation of an acetylcholine receptor promoter

Molecular and Cellular Biology

Volumn 16, Issue 9, 1996, Pages 5004-5014

  Fyodorov, Dmitry ^a   Deneris, Evan ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR;

ACETYLCHOLINE RELEASE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING COMPETITION; BINDING SITE; DNA BINDING; GENE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0029746479     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.9.5004     Document Type: Article

References (56)

1. Anderson, B., M. D. Schonemann, R. V. Pearse II, K. Jeune, J. Sugarman, and M. G. Rasenfeld. 1993. Brn-5 is a divergent POU domain factor highly expressed in layer IV of the neocortex. J. Biol. Chem. 268:23390-23398.
2. Bodner, M., J.-L. Castrillo, L. E. Theill, T. Deerinck, M. Ellisman, and M. Karin. 1988. The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein. Cell 55:505-518.
3. Catron, K. M., H. Zhang, S. C. Marshall, J. A. Inostroza, J. M. Wilson, and C. Abate. 1995. Transcriptional repression by Msx-1 does not require homeodomain DNA-binding sites. Mol. Cell. Biol. 15:861-871.
4. Das, G., C. S. Hinkley, and W. Herr. 1995. Basal promoter elements as a selective determinant of transcriptional activator function. Nature (London) 374:657-660.
5. Dechesne, C. A., Q. Wei, J. Eldridge, L. Gannoun-Zaki, P. Millasseau, L. Bougueleret, D. Caterina, and B. M. Paterson. 1994. E-box and MEF-2-independent muscle-specific expression, positive autoregulation, and cross-activation of the chicken MyoD (CMD1) promoter reveal an indirect regulatory pathway. Mol. Cell. Biol. 14:5474-5486.
6. Faus, I., H.-J. Hsu, and E. Fuchs. 1994. Oct-6: a regulator of keratinocyte gene expression in stratified squamous epithelia. Mol. Cell. Biol. 14:3263-3275.
7. Gerrero, M. R., R. J. McEvilly, E. Turner, C. R. Lin, S. O'Connell, K. J. Jenne, M. V. Hobbs, and M. G. Rosenfeld. 1993. Brn-3.0: a POU-domain protein expressed in the sensory, immune, and endocrine systems that functions on elements distinct from known octamer motifs. Proc. Natl. Acad. Sci. USA 90:10841-10845.
8. Gerster, T., C.-G. Balmaceda, and R. G. Roeder. 1990. The cell type-specific octamer transcription factor OTF-2 has two domains required for the activation of transcription. EMBO J. 9:1635-1643.
9. Greene, L. A., and A. S. Tischler. 1982. PC12 pheochromocytoma cell in neurohiology research. Adv. Cell Neurobiol. 3:373-414.
10. Grueneberg, D. A., S. Natesan, C. Alexandre, and M. Z. Gilman. 1992. Human and Drosophila homeodomain proteins that enhance the DNA-binding activity of serum response factor. Science 257:1089-1095.
11. Hayashi, S., and M. P. Scott. 1990. What determines the specificity of action of Drosophila homeodomain proteins? Cell 63:883-894.
12. 0. Mol. Cell. Biol. 11:1739-1744.
13. Hernandez, N., and R. Lucito. 1988. Elements required for transcription initiation of the human U2 snRNA gene coincide with elements required for snRNA 3′ end formation. EMBO J. 7:3125-3134.
14. Herr, W., R. A. Strum, R. G. Clerc, L. M. Corcoran, D. Baltimore, P. A. Sharp, H. A. Ingraham, M. G. Rosenfeld, M. Finney, G. Ruvkun, and H. R. Horvitz. 1988. The POU-domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis etegans unc-86 gene products. Genes Dev. 2:1513-1516.
15. Ingraham, H. A., R. Chen, H. J. Mangalam, H. P. Elsholtz, S. E. Flynn, C. R. Lin, D. M. Simmons, L. Swanson, and M. G. Rosenfeld. 1988. A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 55:519-529.
16. Ingraham, H. A., S. E. Flynn, J. W. Voss, V. R. Albert, M. S. Kapiloff, L. Wilson, and M. G. Rosenfeld. 1990. The POU-specific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA-dependent Pit-1-Pit-1 interactions. Cell 61:1021-1033.
17. Johnson, D. G., L. Carayannopoulos, J. D. Capra, P. W. Tucker, and J. H. Hanke. 1990. The ubiquitous octamer-binding protein(s) is sufficient for transcription of immunoglobulin genes. Mol. Cell. Biol. 10:982-990.
18. Klemm, J. D., M. A. Rould, R. Aurora, W. Herr, and C. O. Pabo. 1994. Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell 77:21-32.
19. LeBowitz, J. H., T. Kobayashi, L. Staudt, D. Baltimore, and P. A. Sharp. 1988. Octamer-binding proteins from B or HeLa cells stimulate transcription of the immunoglobulin heavy-chain promoter in vitro. Gene Dev. 2:1227-1237.
20. Lenardo, M., J. Pierce, and D. Baltimore. 1987. Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science 236:1573-1577.
21. Li, P., X. He, M. R. Gerrero, M. Mok, A. Aggarwal, and M. G. Rosenfeld. 1993. Spacing and orientation of bipartite DNA-binding motifs as potential functional determinants for POU domain factors. Genes Dev. 7:2483-2496.
22. Mathis, J. M., D. M. Simmons, X. He, L. W. Swanson, and M. G. Rosenfeld. 1992. Brain-4: a novel mammalian POU domain transcription factor exhibiting restricted brain-specific expression. EMBO J. 11:2551-2561.
23. Meijer, D., A. Graus, and G. Grosveld. 1992. Mapping the transactivation domain of the Oct-6 POU transcription factor. Nucleic Acids Res. 20:2241-2247.
24. Meijer, D., A. Grans, R. Kraay, A. Langeveld, M. P. Mulder, and G. Grosveld. 1990. The octamer binding factor Oct-6: cDNA cloning and expression in early embryonic cells. Nucleic Acids Res. 18:7357-7365.
25. 0 gene by the POU transcription factor SCIP. Mech. Dev. 42:15-32.
26. Monuki, E., R. Kuhn, and G. Lemke. 1993. Cell-specific action and mutable structure of a transcription factor effector domain. Proc. Natl. Acad. Sci. USA 90:9978-9982.
27. Monuki, E., R. Kuhn, G. Weinmaster, B. D. Trapp, and G. Lemke. 1990. Expression and activity of the POU transcription factor SCIP. Science 249: 1300-1303.
28. Müller, M. M., S. Ruppert, W. Schaffner, and P. Matthias. 1988. A cloned octamer transcription factor stimulates transcription from lymphoid-specific promoters in non-B cells. Nature (London) 336:544-551.
29. Müller-Immerglück, M. M., W. Schaffner, and P. Matthias. 1990. Transcription factor Oct-2A contains functionally redundant activating domains and works selectively from a promoter but not a remote enhancer position in non-lymphoid (HeLa) cells. EMBO J. 9:1625-1634.
30. Murphy, S., J.-B. Yoon, T. Gerster, and R. G. Roeder. 1992. Oct-1 and Oct-2 potentiate functional interactions of a transcription factor with the proximal sequence element of small nuclear RNA genes. Mol. Cell. Biol. 12:3247-3261.
31. Nelson, C., V. R. Albert, H. P. Elsholtz, L. I.-W. Lu, and M. G. Rosenfeld. 1988. Activation of cell-specific expression of rat growth hormone and prolactin genes by a common transcription factor. Science 239:1400-1405.
32. Okamoto, K., H. Okazawa, A. Okuda, M. Sakai, M. Muramatsu, and H. Hamada. 1990. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 60:461-472.
33. Renner, K., H. Leger, and M. Wegner. 1994. The POU domain protein Tst-1 and papovaviral large tumor antigen function synergistically to stimulate glia-specific gene expression of JC virus. Proc. Natl. Acad. Sci. USA 91:6433-6437.
34. Riggs, K. J., S. Saleque, K.-K. Wong, K. T. Merrel, J.-S. Lee, Y. Shi, and K. Calame. 1993. Yin-yang 1 activates the c-myc promoter. Mol. Cell. Biol. 13:7487-7495.
35. Rosenfeld, M. G. 1991. POU-domain transcription factors: pou-er-ful developmental regulators. Genes Dev. 5:897-907.
36. Sauer, F., S. K. Hansen, and R. Tjian. 1995. Multiple TAFIIs directing synergistic activation of transcription. Science 279:1783-1788.
37. Scheidereit, C., A. Heguy, and R. G. Roeder. 1987. Identification and purification of a human lymphoid-specific octamer-hinding protein (OTF-2) that activates transcription of an immunoglohulin promoter in vitro. Cell 51:783-793.
38. Schöler, H. R., G. R. Dressler, R. Balling, H. Rohdewohld, and P. Gruss. 1990. Oct-4: a germline-specific transcription factor mapping to the mouse t-complex. EMBO J. 9:2185-2195.
39. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffer. 1989. Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res. 17:6419.
40. Stern, S., and W. Herr. 1991. The herpes simplex virus trans-activator VP16 recognizes the Oct-1 homeo domain: evidence for a homeo domain recognition subdomain. Genes Dev. 5:2555-2666.
41. Stern, S., M. Tanaka, and W. Herr. 1989. The Oct-1 homeodomain directs formation of a multiprotein-DNA complex with the HSV transactivator VP16. Nature (London) 341:624-630.
42. Strubin, M., J. W. Newell, and P. Matthias. 1995. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell 80:497-506.
43. Sturm, R. A., and W. Herr. 1988. The POU domain is a bipartite DNA-binding structure. Nature (London) 336:601-604.
44. Suzuki, N., H. Rohdewohld, T. Neuman, P. Grass, and H. R. Schöler. 1990. Oct-6: a POU transcription factor expressed in embryonal stem cells and in the developing brain. EMBO J. 9:3723-3732.
45. Tanaka, M., and W. Herr. 1990. Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell 60:375-386.
46. Tanaka, M., J.-S. Lai, and W. Herr. 1992. Promoter-selective activation domains in Oct-1 and Oct-2 direct differential activation of an snRNA and mRNA promoter. Cell 68:755-767.
47. Treacy, M. N., and M. G. Rasenfeld. 1992. Expression of a family of POU-domain protein regulatory genes during development of the central nervous system. Annu. Rev. Neurosci. 15:139-165.
48. Verrijzer, C. P., and P. C. Van der Vliet. 1993. POU domain transcription factors. Biochim. Biophys. Acta 1173:1-21.
49. Voss, J. W., L. Wilson, and M. G. Rosenfeld. 1991. POU-domain proteins Pit-1 and Oct-1 interact to form a heteromeric complex and can cooperate to induce expression of the prolactin promoter. Genes Dev. 5:1309-1320.
50. Walker, S., S. Hayes, and P. O'Hare. 1994. Site-specific conformational alteration of the Oct-1 POU domain-DNA complex as the basis for differential recognition by Vmw65 (VP16). Cell 79:841-852.
51. Wegner, M., D. W. Drolet, and M. G. Rosenfeld. 1993. Regulation of JC virus by the POU-domain transcription factor Tst-1: implications for progressive multifocal leukoencephalopathy. Proc. Natl. Acad. Sci. USA 90:4743-4747.
52. Wegner, M., D. W. Drolet, and M. G. Rosenfeld. 1993. POU-domain proteins: structure and function of developmental regulators. Curr. Opin. Cell Biol. 5:488-498.
53. Weinstein, D. E., P. G. Burrola, and G. Lemke. 1995. Premature Schwann cell differentiation and hypermyelination in mice expressing a targeted antagonist of the POU transcription factor SCIP. Mol. Cell. Neurosci. 6:212-229.
54. Wirth, T., L. Staudt, and D. Baltimore. 1987. An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity. Nature (London) 329:174-178.
55. Yang, X., D. Fyodorov, and E. Deneris. 1995. Transcriptional analysis of acetylcholine receptor α3 gene promoter motifs that bind Sp1 and AP2. J. Biol. Chem. 270:8514-8520.
56. Yang, X., J. McDonough, D. Fyodorov, M. Morris, F. Wang, and E. S. Deneris. 1994. Characterization of an acetylcholine receptor α3 gene promoter and its activation by the POU-domain factor, SCIP/Tst-1. J. Biol. Chem. 269:10252-10264.